Align Technology, Inc.

ALGN Healthcare Medical Instruments & Supplies

Align Technology, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $4.0 billion, up 0.90% from fiscal 2024.

Revenue
+1.92%
EPS
+143.9%
Free cash flow
+8.26%

Quarter to September 2026, against a year earlier

164.90 5.53 +3.47%
Market cap
$11.3B
P/E
23.1×
Fwd P/E
20.4×
Dividend yield
—
F-score
6/9
Altman Z
4.73
Beneish M
−2.52
Dividend safety
n/a

Align Technology, Inc. (ALGN) Operating cash flow

Alert me on Operating cash flow

Align Technology, Inc.'s operating cash flow for fiscal 2025 was $593.2M, down 19.6% from $738.2M in fiscal 2024. Over the twelve months to 30 September 2026 it was $749.9M. Over the past ten years it has ranged from $238.0M (fiscal 2015) to $1.2B (fiscal 2021); the current reading is higher than 55% of that period. Align Technology, Inc. ranks 8th of 51 Medical Instruments & Supplies companies by operating cash flow.

Operating cash flow, annual

Embed this chart

Annual newest first

Period Operating cash flow Change
FY2025 $593.2M (19.64%)
FY2024 $738.2M (6.05%)
FY2023 $785.8M 38.16%
FY2022 $568.7M (51.50%)
FY2021 $1.2B 77.07%
FY2020 $662.2M (11.39%)
FY2019 $747.3M 34.72%
FY2018 $554.7M 26.48%
FY2017 $438.5M 77.08%
FY2016 $247.7M 4.06%

Quarterly newest first

Period Operating cash flow Change
Sep 2026 $182.9M (5.10%)
Jun 2026 $192.8M 27.62%
Mar 2026 $151.0M (32.32%)
Dec 2025 $223.2M 18.26%
43 more quarters

Against its own ten years

Low $238.0M High $1.2B
Ten-year median $593.2M
Current reading's percentile 55

Operating cash flow against peers

What Operating cash flow is

Operating Cash Flow shows how much cash a company’s day-to-day business actually brings in, after paying suppliers, staff and taxes.

Reported line item

The full definition of Operating cash flow →

More on ALGN